About us

Energenesis Biomedical has signed a technical service contract with National Taiwan University and Yen Ching Ling Industrial Development Foundation to jointly establish an Industrial Research Center. The project will be conducted through industry-academia collaboration and is titled "Initial Exploration of Applying Artificial Intelligence to Assist in New Drug Development."

The collaboration aims to explore the application of generative pre-trained models in the field of bioinformatics. The project plans to utilize NVIDIA Clara Discovery for drug development exploration. Additionally, the parties hope to apply for BioNeMo early access in the future to seize opportunities for joint development of AI-based drug discovery models with international pharmaceutical companies, ultimately achieving the goal of commercializing the products.